VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,806,415 | -7.1% | 73,641 | -11.9% | 0.00% | 0.0% |
| Q1 2023 | $1,944,464 | -61.2% | 83,561 | -57.8% | 0.00% | -63.6% |
| Q4 2022 | $5,011,127 | -25.0% | 197,990 | -42.8% | 0.01% | -26.7% |
| Q3 2022 | $6,678,000 | +2.4% | 346,276 | +35.2% | 0.02% | +15.4% |
| Q2 2022 | $6,524,000 | -55.8% | 256,076 | -27.3% | 0.01% | -51.9% |
| Q4 2021 | $14,746,000 | +478.0% | 352,171 | +500.8% | 0.03% | +145.5% |
| Q3 2021 | $2,551,000 | +25.8% | 58,619 | +48.2% | 0.01% | +22.2% |
| Q1 2021 | $2,028,000 | – | 39,560 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |